Sign in
cache/89f766ad26ef08d3692a413bb90df99f1f1ea1bb4ef4b8e10c78cf32a1f758a4

EURONEXT:MDMA

Pharmala Biotech Holdings Inc.

  • Stock

Last Close

0.11

26/07 13:55

Volume Today

15.54K

Avg: 2.03M

PE Ratio

−61.79

PFCF: −36.83

OverviewFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Aug '21
Aug '22
Aug '23
revenue
78.07K
-
532.00K
581.44%
cost of revenue
303
-
2.29K
655.12%
77.90K
3,304.90%
gross profit
-303
-
75.78K
25,110.56%
454.10K
499.22%
selling and marketing expenses
general and administrative expenses
2.51M
-
1.05M
58.18%
1.15M
9.80%
selling general and administrative expenses
2.51M
-
1.05M
58.18%
1.15M
9.80%
research and development expenses
-166.52K
-
other expenses
cost and expenses
2.51M
-
1.06M
57.61%
1.29M
21.75%
operating expenses
2.51M
-
1.06M
57.70%
1.22M
14.67%
interest expense
ebitda
-2.51M
-
-973.45K
61.20%
-693.32K
28.78%
operating income
-2.51M
-
-985.58K
60.72%
-746.09K
24.30%
depreciation and amortization
303
-
12.13K
3,904.95%
52.77K
334.82%
total other income expenses net
-2.08M
-
-3
100.00%
-16.86K
562,000%
income before tax
-2.51M
-
-985.58K
60.72%
-779.81K
20.88%
income tax expense
-2.08M
-
-3
100.00%
16.86K
562,200%
net income
-2.51M
-
-985.58K
60.72%
-779.81K
20.88%
weighted average shs out
83.00M
-
83.00M
0%
84.53M
1.84%
weighted average shs out dil
83.00M
-
83.00M
0%
84.53M
1.84%
eps
-0.03
-
-0.01
60.60%
-0.01
22.69%
epsdiluted
-0.03
-
-0.01
60.60%
-0.01
22.69%

All numbers in (except ratios and percentages)